New Key Statistics Module, Z-Score and F-Score
SZSE:003017 Key Ratios
Market Cap ¥ M | 1,672.44 |
Enterprise Value ¥ M | 1,621.87 |
P/E(ttm) | 26.58 |
PE Ratio without NRI | 23.26 |
Forward PE Ratio | -- |
Price/Book | 1.63 |
Price/Sales | 1.84 |
Price/Free Cash Flow | 22.51 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.99 |
Revenue (TTM) ¥ M | 876.00 |
EPS (TTM) ¥ | 0.75 |
Beneish M-Score | -2.64 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -2.00 |
y-y EBITDA Growth Rate % | -2.50 |
EV-to-EBIT | 22.97 |
EV-to-EBITDA | 22.97 |
PEG | -- |
Shares Outstanding M | 84.00 |
Net Margin (%) | 6.97 |
Operating Margin % | 9.43 |
Pre-tax Margin (%) | 7.11 |
Quick Ratio | 0.97 |
Current Ratio | 1.21 |
ROA % (ttm) | 3.90 |
ROE % (ttm) | 6.06 |
ROIC % (ttm) | 7.06 |
Dividend Yield % | 4.30 |
Altman Z-Score | 2.82 |
SZSE:003017 Number of Guru Trades
SZSE:003017 Volume of Guru Trades
Gurus Latest Trades with SZSE:003017
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:003017 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Dayang Biotech Group Co Ltd Insider Transactions
No Available Data